Related Experiment Video
Updated: Jul 18, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
SFK-STAT pathway: an alternative and important way to malignancies
Fumihiko Hayakawa1, Tomoki Naoe
1Department of Hematology and Oncology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. bun-hy@med.nagoya-u.ac.jp
Annals of the New York Academy of Sciences
|December 23, 2006
Summary
Signal transducers and activators of transcription (STAT) proteins are activated by Src family kinases (SFK) through growth factor signaling. This review explores STAT activation by SFK and its role in oncogenic signals.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Signal transducers and activators of transcription (STAT) proteins are key mediators of cytokine receptor signaling.
- Traditionally, JAK family kinases (JFK) are known to activate STAT proteins.
- Emerging evidence suggests alternative pathways for STAT activation exist.
Purpose of the Study:
- To review the literature on STAT protein activation by Src family kinases (SFK).
- To highlight the role of SFK-mediated STAT activation in growth factor signaling.
- To discuss the aberrant activation of STAT proteins in the context of oncogenic signals.
Main Methods:
- Literature review of STAT protein activation.
- Analysis of experimental data on STAT5 phosphorylation by Lyn (a SFK member).
- Synthesis of findings on SFK and STAT signaling.
Main Results:
- Src family kinases (SFK) can activate STAT proteins, particularly in growth factor signaling pathways.
- STAT5 phosphorylation by Lyn, a member of SFK, has been observed in recent studies.
- Aberrant STAT activation by oncogenic signals is a significant area of investigation.
Conclusions:
- SFK represents an alternative pathway for STAT activation beyond the canonical JFK pathway.
- Understanding SFK-mediated STAT activation is crucial for comprehending growth factor signaling and oncogenesis.
- Further research into aberrant STAT activation by oncogenic signals may reveal new therapeutic targets.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...